Thyroid Cancer Trial, Recruiting NCT06498674 Sponsor: Fujian Medical University Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT06498674
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been confirmed through a tissue sample (biopsy) to have a cancerous thyroid tumour and are having surgery to treat it.
  • People who have a non-cancerous thyroid growth, such as a thyroid adenoma that is causing symptoms like pressure or difficulty swallowing, and are having surgery.
  • People who have complete, clear, and good-quality standard thyroid ultrasound images available.
  • People who have a full and complete report from their pathology (lab analysis of tissue removed during surgery).
  • People who are willing to take part in the trial and have signed a consent form agreeing to participate.

Who may not be able to join:

  • People who have previously had surgery or radiation therapy on their neck.
  • People who have a history of cancer in any other part of the body.
  • People who have a thyroid condition affecting how the thyroid gland functions (such as an overactive or underactive thyroid).
  • People whose thyroid ultrasound images are incomplete or not of good enough quality.
  • People whose post-surgery pathology report is incomplete.
  • People who do not wish to take part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13959123550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Medical University
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Supplementary Pathological Examination; Change in Treatment Decision

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov